SPY
769.94
−0.24%
QQQ
717.88
−1.39%
BTC/USD
81,657.13
−0.58%
DIA
523.06
+0.38%
GLD
383.40
+0.18%
TLT
80.28
+0.38%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
IRIDEX Corp
IRIX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.8177
-0.00675
-0.82%
Last update: Oct 16, 10:32 AM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Options
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Iridex Financials
Iridex (IRIX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est
Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.
Benzinga Newsdesk
PRO
Iridex Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $12.566M Miss $13.587M Estimate
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is a 16.67 percent decrease over losses of $(0.06) per share from the same
Benzinga Newsdesk
PRO
Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est
Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.
Benzinga Newsdesk
PRO
Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(0.10) per share from the same
Benzinga Newsdesk
Earnings Scheduled For May 19, 2026
Benzinga Insights
PRO
Iridex Sees FY2026 Sales $51.000M-$53.000M vs $56.549M Est.
Iridex (NASDAQ:IRIX) sees FY2026 sales of $51.000 million-$53.000 million vs $56.549 million analyst estimate.
Benzinga Newsdesk
